PHIO phiopharma.com: Bozor kapitallashuvining balans qiymatiga nisbati

RXi Pharmaceuticals (PHIO) kompaniyasining rasmiy ramzlari

Phio Pharmaceuticals (PHIO) kompaniyasining istiqbollari ko'z va teri patologiyalarini davolashda RNK interferentsiyasi usullarining samaradorligiga, shuningdek, patent himoyasiga bog'liq. 0.83 metrikasiga ega bo'lgan ushbu narxlar grafigi kliniklarda o'simtaga qarshi dori vositalari sinovlarining kengayishi bo'yicha ma'lumotlarni to'ldiradi. Shu bilan birga, biznes chiqindilarni qayta ishlashni optimallashtirish va hamyonbop dori vositalarini yaratishda qat'iy etika qoidalariga rioya qilish orqali ESG tamoyillarini joriy etmoqda.

phiopharma.com (PHIO): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha

PHIO (Phio Pharmaceuticals): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi phiopharma.com|PHIO - Oʻrtacha prognoz narxi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi RXi Pharmaceuticals|PHIO - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Phio Pharmaceuticals|PHIO - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati phiopharma.com|PHIO - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Phio Pharmaceuticals|PHIO - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati phiopharma.com|PHIO - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar RXi Pharmaceuticals
Kompaniyaning dastlabki tahlili:Phio Pharmaceuticals Corp (PHIO)
Phio Pharmaceuticals brend mahsuloti

Ushbu ko'rsatkich kompaniyaning bozor qiymatini uning sof aktivlariga solishtirib, investorlarning kelajakdagi kutganlari uchun qo'shimcha qiymatni o'lchaydi. Phio Pharmaceuticals (PHIO) uchun ushbu farq noyob INTASYL platformasining qiymatini va RNA molekulalarining patent himoyasini aks ettiradi. Bozor qiymatining kitob kapitalizatsiyasi nisbatidagi o'zgarishlarni tahlil qilish orqali fundamental o'sishni spekulyatsiyadan ajratish mumkin. Ushbu tendentsiya intellektual kapitalning bozor bahosini aniqlaydi. Barqaror tendentsiya ushbu biotexnologik aktivning uzoq muddatli investitsiya jozibadorligini tasdiqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Bozor qiymatining balans qiymatiga nisbati TEM|qiagen.com (QGEN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|ultragenyx.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Beam Therapeutics|SRPT - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Twist Bio TWST|10x (TXG) - Balans qiymatiga nisbatan bozor qiymati|NTLA: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi STOK|BioLife Solutions - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Wave Life Sciences Ltd WVE|Kapitallashuvning sof aktivlarga nisbati Maze Tx|Sionna Corp - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Prime Medicine, Inc.|TSHA - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati uniQure QURE|MeiraGTx Holdings (MGTX) - Balans qiymatiga nisbatan bozor qiymati|RGNX (Regenxbio) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SLDB|Ocugen, Inc. (OCGN) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati PACB (pacb.com)|Benitec Biopharma - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Design Therapeutics Inc DSGN|Rocket Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|FDMT - Bozor kapitallashuvining balans qiymatiga nisbati|LXEO (lexeotx.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Korro Bio (KRRO) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati EDIT (Editas Medicine)|Bozor qiymatining balans qiymatiga koeffitsiyenti Silence Therapeutics PLC (SLN)|Kapitallashuvning sof aktivlarga nisbati PRQR|Bozor kapitallashuvining balans qiymatiga nisbati codexis.com CDXS|Kapitallashuvning sof aktivlarga nisbati Sangamo Therapeutics (SGMO)|Bozor kapitallashuvining balans qiymatiga multiplikatori Nautilus Biotechnology, Inc. NAUT|Bozor kapitallashuvining balans qiymatiga nisbati MGX (Metagenomi)|DTIL - Balans qiymatiga nisbatan bozor kapitallashuvi|GBIO (generationbio.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Boundless Bio Inc (BOLD) - Kapitallashuvning sof aktivlarga nisbati|XCUR (Exicure Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IMNN|Bozor qiymatining balans qiymatiga nisbati Mustang Bio, Inc. (MBIO)|Bozor qiymatining balans qiymatiga nisbati RNAZ (transcodetherapeutics.com)|Bozor qiymatining balans qiymatiga nisbati BNGO|Applied DNA Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati bluebird bio, Inc.|IPA - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Omega Therapeutics, Inc. OMGA|Singular Genomics Systems, Inc. (OMIC) - Balans qiymatiga nisbatan bozor qiymati|RGLS: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi SYRS|Telesis Bio, Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti traconpharma.com (TCON)|UBX - Bozor kapitallashuvining balans qiymatiga nisbati